Bone Grafts and Substitutes Market: Growth & Revenue Opportunities by Top Key Players Arthrex, Inc., Baxter International Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson and more

The Bone Grafts and Substitutes Market was valued at $ 2,690 million in 2017 and is expected to grow at an annual average rate of 4.8% from 2018 to 2025, reaching $ 3,912 million by 2025.

Bone grafting is an implantable material that promotes bone healing, bone formation, and bone reconstruction.
Increased incidence of musculoskeletal disorders, advances in medical technology that lead to a transition from autologous to allograft, and increased preference for biocompatible bone grafts are key contributors to the growth of bone graft and substitute markets worldwide. In the case of lifestyle disorders such as diabetes and obesity, the risk of developing degenerative joint disease increases, thereby promoting market growth. However, the major pharmaceuticals in this market are ethical issues related to bone transplantation and high surgical costs.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1774?utm_source=sy-Openpr

The key players profiled in this report include
• Arthrex Inc.
• Baxter International Inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson (DePuy Synthes)
• Medtronic Plc.
• Musculoskeletal Transplant Foundation
• NuVasive Inc.
• Stryker Corporation
• Wright Medical Group N.V.
• Zimmer Biomet Holdings Inc.

Cell based matrices (CBM) is projected to grow at the highest CAGR of 6.1% from 2018 to 2025, as these materials serve as a cell-based bone grafts substitutes that use cells to generate tissue alone or in combination with support matrix. In addition, the advantages offered by CBM such as reproducibility and cost-effectiveness have fueled the market growth.

Spinal fusion accounted for the major share of the total market in 2017, as bone grafts and their substitutes are widely used in the spine fusion procedures worldwide However, the joint reconstruction segment is poised to grow at the highest CAGR of 6.2% during the forecast period, due to upsurge in incidence of bone and joint disorders.

Get Discount UP To 25% * Offer Till 31st Dec 2018@ Get Discount UP To 25% * Offer Till 31st Dec 2018@ https://www.alliedmarketresearch.com/checkout/936491?utm_source=sy-Openpr

Key Findings of the Bone Grafts and Substitutes Market:
• Bone graft substitutes segment dominated the overall market with a share of more than half of the overall market in 2017, and is expected to continue to lead the during the forecast period.
• Asia-Pacific is expected to witness highest market growth rate, with a CAGR of 7.3% from 2018-2025
• U.S. accounted for more than half of the overall market in 2017, whereas South Korea is expected to register the highest CAGR of 9.7%.

North America held the dominant position in the global market in 2017, and is expected to maintain its lead throughout the analysis period. This is attributed to rise in incidence of spinal fusion & joint reconstruction procedures, sedentary lifestyle contributing to joint disorders in the geriatric & younger population, and favorable reimbursement rates in the region.

Access Full Summery @ https://www.alliedmarketresearch.com/bone-graft-substitutes-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.